Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.37 |
| ▸ | TDO2 | P48775 | 5/20 | 0.37 |
| ▸ | DHODH | Q02127 | 8/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21532771 | 0.98 | IDO1 (0.37) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL21532360 | 0.92 | IDO1 (0.37) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL17636628 | 0.92 | IDO1 (0.43) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL21532509 | 0.91 | L3MBTL1 (0.36) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL21532510 | 0.91 | L3MBTL1 (0.36) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL17636681 | 0.90 | IDO1 (0.42) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL21532768 | 0.90 | L3MBTL1 (0.35) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL21532764 | 0.90 | L3MBTL1 (0.35) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL21532733 | 0.90 | IDO1 (0.37) | IDO1TDO2DHODHKDM4EATM | |
| SCHEMBL15762174 | 0.88 | KDM4E (0.41) | IDO1TDO2DHODHKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11145825-B2 | Condensed cyclic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
| US-20190334095-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145825-B2 | Condensed cyclic compound and organic light-emitting device including i he same | CRY1, CCNT1, CCNA1 | IDO1 1516/4885TDO2 2702/4885DHODH 4012/4885 |
| US-20190334095-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, ARL1 | IDO1 2155/4885TDO2 2389/4885DHODH 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.